Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J C Kando

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
The Journal of Clinical Psychiatry|October 1, 1993
Adverse behavioral events reported in patients taking alprazolam and other benzodiazepinesJ O Cole, J C Kando
Journal of Clinical Psychopharmacology|October 1, 1994
Sertraline treatment of attention deficit hyperactivity disorder and Tourette's syndromeF R Frankenburg, J C Kando
The American Journal of Psychiatry|July 1, 1995
Hospital use of antipsychotic agents in 1989 and 1993: stable dosing with decreased length of stayR J Baldessarini, J C Kando, F Centorrino
Drugs|July 1, 1995
Gender as a risk factor for adverse events to medicationsJ C Kando, K A Yonkers, J O Cole
The Journal of Clinical Psychiatry|June 1, 1994
Concurrent use of clozapine and valproate in affective and psychotic disordersJ C Kando, M Tohen, J Castillo, et al.
DICP : the Annals of Pharmacotherapy|May 1, 1990
Pergolide-induced hypotensionJ C Kando, P E Keck, P A Wood
The Journal of Clinical Psychiatry|June 1, 1996
The use of valproate in an elderly population with affective symptomsJ C Kando, M Tohen, J Castillo, et al.
The American Journal of Psychiatry|May 1, 1992
Gender differences in pharmacokinetics and pharmacodynamics of psychotropic medicationK A Yonkers, J C Kando, J O Cole, et al.
The Journal of Clinical Psychiatry|January 1, 1996
Bladder dysfunction associated with clozapine therapyF R Frankenburg, J C Kando, F Centorrino, et al.
The American Journal of Psychiatry|March 1, 1995
Blood dyscrasias with carbamazepine and valproate: a pharmacoepidemiological study of 2,228 patients at riskM Tohen, J Castillo, R J Baldessarini, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
The Journal of Clinical Psychiatry|October 1, 1993
Adverse behavioral events reported in patients taking alprazolam and other benzodiazepinesJ O Cole, J C Kando
Journal of Clinical Psychopharmacology|October 1, 1994
Sertraline treatment of attention deficit hyperactivity disorder and Tourette's syndromeF R Frankenburg, J C Kando
The American Journal of Psychiatry|July 1, 1995
Hospital use of antipsychotic agents in 1989 and 1993: stable dosing with decreased length of stayR J Baldessarini, J C Kando, F Centorrino
Drugs|July 1, 1995
Gender as a risk factor for adverse events to medicationsJ C Kando, K A Yonkers, J O Cole
The Journal of Clinical Psychiatry|June 1, 1994
Concurrent use of clozapine and valproate in affective and psychotic disordersJ C Kando, M Tohen, J Castillo, et al.
DICP : the Annals of Pharmacotherapy|May 1, 1990
Pergolide-induced hypotensionJ C Kando, P E Keck, P A Wood
The Journal of Clinical Psychiatry|June 1, 1996
The use of valproate in an elderly population with affective symptomsJ C Kando, M Tohen, J Castillo, et al.
The American Journal of Psychiatry|May 1, 1992
Gender differences in pharmacokinetics and pharmacodynamics of psychotropic medicationK A Yonkers, J C Kando, J O Cole, et al.
The Journal of Clinical Psychiatry|January 1, 1996
Bladder dysfunction associated with clozapine therapyF R Frankenburg, J C Kando, F Centorrino, et al.
The American Journal of Psychiatry|March 1, 1995
Blood dyscrasias with carbamazepine and valproate: a pharmacoepidemiological study of 2,228 patients at riskM Tohen, J Castillo, R J Baldessarini, et al.
Pageof 2